Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in this clinical context.
Daily Archives: 7 May 2020
A covid-19 infection starts as a local upper respiratory tract infection, but can spread to affect multiple organ systems with consequences that are only now being understood. When it does spread in this way, the result is multi-system critical illness associated with a high risk of death.
Doctors have expressed concern over new guidance from Public Health England that recommends reusing personal protective equipment in the face of shortages.1 The guidance, which also recommends alternatives for unavailable equipment, has been seen as an admission by the government of the PPE shortages facing healthcare staff. Rob Harwood, chair of the BMA’s Consultants Committee, said, “This guidance is a further admission of the dire situation that some doctors and healthcare workers continue to find themselves in because of government failings.
This fact sheet provides an overview of the public health initiative COVIDSafe – a mobile contact tracing app launched by the Australian Government in response to COVID-19.
Question: What was the initial experience in Singapore with the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Findings: In this descriptive case series of the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore between January 23 and February 3, 2020, clinical presentation was a respiratory tract infection with prolonged viral shedding from the nasopharynx of 7 days or longer in 15 patients (83%). Supplemental oxygen was required in 6 patients (33%), 5 of whom were treated with lopinavir-ritonavir, with variable clinical outcomes following treatment. Meaning: These findings provide clinical features and course among patients diagnosed with SARS-CoV-2 infection in Singapore.
The NABH Digital Health Standards aims to consider all relevant aspects of the application of patient interfacing technologies across the continuum of care applicable for outpatient, inpatient, and remote patient monitoring. Digital technologies in Indian healthcare are certainly witnessing huge adoption due to the lockdown imposed to reduce the spread of the coronavirus disease Covid-19. A major step towards ensuring the quality of healthcare and patient safety has been taken by the National Accreditation Board for Hospitals and Healthcare Providers (NABH) which has initiated the work on standards for digital health.